NHS Scotland recommends Janssen’s Zytiga combo for newly diagnosed prostate cancer
January 13, 2020Sales and Marketing Cancer, NHS, Scotland, nhs scotland, prostate cancer
Janssen’s Zytiga (abiraterone acetate) has just been approved by the Scottish Medicines Consortium (SMC), meaning that male patients on the …
Working Life Interview: Jean-Paul Kress, CEO of MorphoSys
January 13, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Working Life, feature, morphosys, pharma
With a medical doctorate as well as degrees in pharmacology and immunology under your belt, was your path always to …
FDA approves Astellas injectable antifungal drug for newborns
January 13, 2020Sales and Marketing Astellas, Atellas Pharma, FDA, fungal virsus
The FDA has approved the first antifungal drug to specifically treat invasive candidiasis in newborns. From Astellas, the new drug …
Eli Lilly to boost immunology portfolio with $1.1bn Dermira acquisition
January 13, 2020Sales and Marketing Dermira, Eli Lilly, pharma
Eli Lilly has announced it has entered into an agreement to acquire Dermira, a biopharmaceutical firm focused on the development …
Pakistan registers cases against 200 pharmaceutical companies
January 13, 2020Sales and Marketing National Task Force, Pakistan, Pakistani Pharmaceuticals, corruption
The Punjab Quality Control Board has sent at least 74 cases to the drugs courts for prosecution, and has overall …
AstraZeneca to discontinue trial for heart disease drug Epanova
January 13, 2020Sales and Marketing AstraZeneca, Phase II Trial, Phase III trial, heart disease, triglycerides
AstraZeneca expects a $100 million writedown for its heart disease drug Epanova, as it discontinues its late stage trial. This …
Bayer and Exscientia to work together on AI in cardiovascular and oncology drug discovery
January 10, 2020Medical Communications Bayer, Exscientia, oncology
Bayer AG has partnered with Exscientia to accelerate the discovery of small molecule drugs focused on cardiovascular disease and oncology. …
Sanofi secures expanded European approval for Toujeo in type 1 diabetes
January 10, 2020Medical Communications, Sales and Marketing EU, Sanofi, pharma, toujeo
Sanofi has revealed that the European Commission has expanded the existing label for Toujeo (insulin glargine 300 units/mL) to include …
Idorsia reveals it is working with Neurocrine on new epilepsy drug deal
January 10, 2020Medical Communications FDA, Idorsia, Neurocrine, drugs, epilepsy, pharma
Idorsia revealed its 2019 deal for its investigational epilepsy medicine was with Neurocrine Biosciences, and it is potentially worth more …
US approval for Blueprint Medicines’ gastrointestinal stromal tumour therapy
January 10, 2020Medical Communications, Sales and Marketing Ayvakit, Blueprint Medicines, Cancer, pharma
The FDA has moved to authorise Blueprint Medicines’ kinase inhibitor Ayvakit (avapritinib) for the treatment of unresectable or metastatic gastrointestinal …
Top Ten most popular articles on Pharmafile.com this week
January 10, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The US pharamaceutical industry dominates the news this week, with Pfizer, Sanofi and GlaxoSmithKline all increasing their drug prices while …
MSD’s Keytruda chalks up bladder cancer approval in the US
January 9, 2020Sales and Marketing Cancer, MSD, bladder cancer, keytruda, pharma
MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) has added another US approval to its repertoire with the news that FDA has awarded …
WHO says Chinese pneumonia outbreak may be a new virus
January 9, 2020Business Services Bird Flu, Hong Kong, Singapore, WHO, chinese, pneumonia
The recent pneumonia outbreak in Wuhan could potentially be a new virus, according to the World Health Organisation (WHO). The …
Novartis’ ligelizumab tops Xolair in chronic spontaneous urticaria
January 9, 2020Research and Development Novartis, Xolair, ligelizumab
Novartis has provided a burst of new data directly comparing its therapy ligelizumab with the current standard of care Xolair …
Diabetes drug could increase stem cells in the womb to treat recurrent miscarriage
January 9, 2020Business Services Stem cells, diabetes, insulin, miscarraiges, pregnancy
A study led by the University of Warwick found that sitagliptin, a diabetes drug, could be used to treat recurrent …
Largest drop ever in US cancer mortality rates, new study shows
January 9, 2020Business Services Cancer, brain cancer, lung cancer, prostate cancer
The overall cancer mortality rate in the US fell by 2.2% from 2016 to 2017, the largest ever annual decline …
China approves first homegrown HPV vaccine
January 8, 2020Research and Development, Sales and Marketing China, HPV, NMPA, pharma, vaccines
Female patients in China between the ages of nine and 45 will have access to the country’s first domestically-produced vaccine …
No link between talc and ovarian cancer, new study reveals
January 8, 2020Research and Development . Johnson & Johnson, Johnson & Johnson, baby powder, talc, talc powder
Researchers examining data from over 252,000 women have concluded that there is no statistically significant link between the use of …
Apellis therapy outflanks Alexion’s Soliris in head-to-head paroxysmal nocturnal haemoglobinuria
January 8, 2020Research and Development Alexion, Appelis, pegcetacoplan, pharma, soliris
Apellis Pharmaceuticals has revealed new Phase 3 demonstrating that its targeted C3 inhibitor pegcetacoplan met its primary endpoint and outclassed …
Pharmacies argue that prescribers bear ultimate responsibility for the opioid crisis
January 8, 2020Research and Development Bernie Sanders, OxyContin, opioid crisis, opioids
Pharmacy chains have argued in federal court that doctors and healthcare practitioners who write prescriptions bear ultimate responsibility for the …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
